US Firm To Trial Bird Flu Vaccine In Indonesia And Hong Kong

EPIDEMICS

Indonesian Health Minister Siti Fadilah Supari has said that Indonesia would aim to produce about 20 million doses of the vaccine, for 10 percent of the population, in case of a pandemic.

by Staff Writers
Jakarta (AFP) May 30, 2007
A US company will soon conduct clinical trials of a bird flu vaccine in Singapore and Hong Kong, a health ministry official said here Wednesday. Baxter Healthcare will carry out the trials in the two nations using a strain of the virus found in Indonesia, the nation worst hit by bird flu with 77 deaths, the official said.

"Clinical trials will start in July this year in Singapore and Hong Kong," said Endang Rahayu Sedyaningsih from the Indonesian health ministry.

"Ninety-eight people will participate on the trial," she said.

Sedyaningsih, who heads biomedics, pharmacy research and development at the ministry, said Singapore and Hong Kong were already prepared for the trial.

Indonesia signed an agreement with Baxter in February to develop a human bird flu vaccine and ensure it benefits from any treatment for the deadly virus.

Indonesian Health Minister Siti Fadilah Supari has said that Indonesia would aim to produce about 20 million doses of the vaccine, for 10 percent of the population, in case of a pandemic.

The World Health Organisation says the H5N1 strain of the virus has infected at least 282 people and killed about 170, mostly in Southeast Asia, since the end of 2003.

Source: Agence France-Presse

Email This Article

EPIDEMICS

Avian Influenza Survivor Antibodies Effective At Neutralising H5N1 Strain

London (SPX) May 30, 2007
Adults who have recovered from the potentially deadly H5N1 strain of avian influenza may hold the key to future treatments for the virus, according to an international team of researchers. In a study published today in the open access journal PLoS Medicine, the researchers have shown how specific antibodies taken from avian flu survivors in Vietnam can be reproduced in the laboratory and prove effective at neutralising the virus in culture vitro and in mice.

DISASTER MANAGEMENT Locals Block Work At Indonesian Mud Volcano Steel Dam Plan To Plug Indonesian Mud Volcano Chinese Space Agency Joins The International Charter Space And Major Disasters LSU And Los Alamos Team Up To Improve Evacuation Plans	CLIMATE SCIENCE NASA Administrator Michael Griffin Not Sure Global Warming A Problem Russia Knows How To Prevent Global Warming Rice Needles Germany On Green Credentials At G8 Meet NASA Research Suggest Earth Climate Approaching Dangerous Point
EARTH OBSERVATION Tracking A Hot Spot In The Center Of The Biggest Ocean On Earth MetOp-A Takes Up Service General Dynamics Awarded Contract For NASA's Landsat Data Continuity Mission Study ESA Presents The Sharpest Ever Satellite Map Of Earth	ENERGY TECH Peabody And Rentech Partner Up For First Commercial US Coal-to-Liquids Facility Consumers Willing To Pay More For Environmentally Responsible Fuels, Including Clean Coal Southern California Edison Assesses Advanced Coal Technologies Hydrogen-Powered Ice Resurfacer Promoted
EPIDEMICS US Firm To Trial Bird Flu Vaccine In Indonesia And Hong Kong Avian Influenza Survivor Antibodies Effective At Neutralising H5N1 Strain System To Pinpoint Airline Passengers Who Contaminate Cabins AIDS Remains Global Worry	FLORA AND FAUNA Researchers Probe The Tiny Building Blocks Of Bones Ants Show Us How To Make Super-Highways Professor Helps Develop Techniques To Reduce Threat Against Honeybees New Wrinkle In Evolution With Man-Made Proteins
FROTH AND BUBBLE Serious Health Risk In Naples Area As Garbage System Backs Up Ukraine, Belarus, Moldova Choking On Toxic Waste Pollution And Chemicals Blamed For Massive Cancer Rate Risa Across China Beijing To Turn Garbage Into Power	ABOUT US Color Vision Drove Primates To Develop Red Skin And Hair Northrop Grumman Dedicates Habitat For Humanity House Exercise Reverses Aging In Human Skeletal Muscle Sweden Mulls Freeze-Drying As New Burial Method

The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement